Intuitive Surgical Reports Lower US Procedure Growth Following ACA Changes
Article excerpt
Intuitive experienced a growth deceleration for U.S. procedures utilizing its da Vinci surgical robots during the second quarter, as reported by Detik Finance, following the expiration of enhanced Affordable Care Act premium subsidies. The medical technology company recorded a second-quarter revenue of $2.89 billion and a net income of $818 million. Total system placements reached 468 units, which included 246 placements of the newer da Vinci 5 model. However, U.S. procedure growth moderated to 12 percent, contrasting with a stronger 20 percent expansion observed in international markets. Following the disclosure, the company's shares dropped 12 percent to $354.26 during Friday morning trading sessions. Company executives identified changes in the broader insurance landscape as a primary factor influencing the clinical slowdown. The enhanced marketplace subsidies concluded at the end of 2025 without a congressional extension, causing lower enrollment numbers and driving patients toward insurance policies featuring higher deductibles. "In our customer conversations, some have said that changes in patient coverage and premium dynamics may be affecting when patients seek care and move forward with treatment," said Dave Rosa, CEO of Intuitive. The administrative head noted that the deceleration primarily impacted elective medical procedures that patients can safely defer...
Keep reading with a free account
The rest of this article, and every signal for Intuitive Surgical, is in your free account.
Extracted from this sentence
The enterprise has submitted a 510(k) application for a noncommercial variant of a flexible robotic endoscope system intended for gastrointestinal tract applications.
